-
Je něco špatně v tomto záznamu ?
Clinicopathological Significance of Pluripotent Factors in Sinonasal Intestinal-Type Adenocarcinoma
F. Monaco, A. Vallieri, L. Volpini, MP. Foschini, A. Filosa, E. Antolini, FM. Gioacchini, G. Sollini, E. Pasquini, G. Iannella, J. Neuzil, M. Amati, L. Santarelli, M. Tomasetti, M. Re
Status neindexováno Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 2009
PubMed Central
od 2009
Europe PubMed Central
od 2009
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2009
PubMed
41463190
DOI
10.3390/cancers17243939
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Background/Objectives: Sinonasal intestinal-type adenocarcinoma (ITAC) is a rare and aggressive tumor with a lack of specific symptoms, which leads to late diagnosis, and is characterized by frequent local recurrence and low survival rate. The stemness phenotype is one of the main causes leading to tumor proliferation, recurrence, and resistance to standard chemo/radiotherapy. Methods: In this study, genes encoding pluripotency-associated transcription factors, including KLF4, c-MYC, SOX2, OCT4 (Yamanaka factors), and NANOG were evaluated in malignant and non-malignant tissues of a cohort of 54 patients with ITAC, and their expression was related to patient outcome. The c-MYC, SOX2, and OCT4 levels were then confirmed in immunohistochemistry by adding ALDH1A1 as a factor involved in stemness. Results: KLF4, SOX2, and NANOG best distinguished cancer tissue from normal tissue with high sensibility and specificity. Low levels of KLF4, c-MYC, and NANOG and high expressions of SOX2 and OCT4 in tumor tissue correlated with poor overall survival (OS) and disease-free survival (DFS), respectively. Through multivariate analysis, type of surgery was found to be a significant prognostic factor along with c-MYC and OCT4. Notably, tumor positivity for c-MYC and ALDH1A1 was associated with longer disease-specific survival, thus suggesting their role as tumor suppressors. Conclusions: Our findings underline the stemness phenotype as a prognostic model for ITAC, supporting the clinical plausibility of Yamanaka factors in sinonasal cancer prediction.
Department of Biomedical and Neuromotor Sciences University of Bologna 40126 Bologna Italy
Department of Clinical and Molecular Sciences Polytechnic University of Marche 60126 Ancona Italy
Department of Sensory Organs La Sapienza University 00185 Rome Italy
ENT Division Bellaria Hospital AUSL Bologna 40124 Bologna Italy
Institute of Biotechnology Czech Academy of Sciences 25250 Prague Czech Republic
School of Pharmacy and Medical Science Griffith University Southport QLD 4222 Australia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc26001660
- 003
- CZ-PrNML
- 005
- 20260122082604.0
- 007
- ta
- 008
- 260116s2025 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/cancers17243939 $2 doi
- 035 __
- $a (PubMed)41463190
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Monaco, Federica $u Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60126 Ancona, Italy $1 https://orcid.org/0000000297983589
- 245 10
- $a Clinicopathological Significance of Pluripotent Factors in Sinonasal Intestinal-Type Adenocarcinoma / $c F. Monaco, A. Vallieri, L. Volpini, MP. Foschini, A. Filosa, E. Antolini, FM. Gioacchini, G. Sollini, E. Pasquini, G. Iannella, J. Neuzil, M. Amati, L. Santarelli, M. Tomasetti, M. Re
- 520 9_
- $a Background/Objectives: Sinonasal intestinal-type adenocarcinoma (ITAC) is a rare and aggressive tumor with a lack of specific symptoms, which leads to late diagnosis, and is characterized by frequent local recurrence and low survival rate. The stemness phenotype is one of the main causes leading to tumor proliferation, recurrence, and resistance to standard chemo/radiotherapy. Methods: In this study, genes encoding pluripotency-associated transcription factors, including KLF4, c-MYC, SOX2, OCT4 (Yamanaka factors), and NANOG were evaluated in malignant and non-malignant tissues of a cohort of 54 patients with ITAC, and their expression was related to patient outcome. The c-MYC, SOX2, and OCT4 levels were then confirmed in immunohistochemistry by adding ALDH1A1 as a factor involved in stemness. Results: KLF4, SOX2, and NANOG best distinguished cancer tissue from normal tissue with high sensibility and specificity. Low levels of KLF4, c-MYC, and NANOG and high expressions of SOX2 and OCT4 in tumor tissue correlated with poor overall survival (OS) and disease-free survival (DFS), respectively. Through multivariate analysis, type of surgery was found to be a significant prognostic factor along with c-MYC and OCT4. Notably, tumor positivity for c-MYC and ALDH1A1 was associated with longer disease-specific survival, thus suggesting their role as tumor suppressors. Conclusions: Our findings underline the stemness phenotype as a prognostic model for ITAC, supporting the clinical plausibility of Yamanaka factors in sinonasal cancer prediction.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vallieri, Alberto $u Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60126 Ancona, Italy $1 https://orcid.org/0009000337509943
- 700 1_
- $a Volpini, Luca $u Institute of Biotechnology, Czech Academy of Sciences, 25250 Prague, Czech Republic $1 https://orcid.org/0000000348308613
- 700 1_
- $a Foschini, Maria P $u Department of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy $1 https://orcid.org/0000000170797260
- 700 1_
- $a Filosa, Alessandra $u Department of Excellence SBSP-Biomedical Sciences and Public Health, Polytechnic University of Marche, 60126 Ancona, Italy
- 700 1_
- $a Antolini, Enrica $u Department of Excellence SBSP-Biomedical Sciences and Public Health, Polytechnic University of Marche, 60126 Ancona, Italy $1 https://orcid.org/0009000318252353
- 700 1_
- $a Gioacchini, Federico Maria $u Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60126 Ancona, Italy
- 700 1_
- $a Sollini, Giacomo $u ENT Division "Bellaria Hospital"-AUSL Bologna, 40124 Bologna, Italy $1 https://orcid.org/0000000265360184
- 700 1_
- $a Pasquini, Ernesto $u ENT Division "Bellaria Hospital"-AUSL Bologna, 40124 Bologna, Italy
- 700 1_
- $a Iannella, Giannicola $u Department of Sensory Organs, La Sapienza University, 00185 Rome, Italy $1 https://orcid.org/0000000317812809
- 700 1_
- $a Neuzil, Jiri $u Institute of Biotechnology, Czech Academy of Sciences, 25250 Prague, Czech Republic $u School of Pharmacy and Medical Science, Griffith University, Southport, QLD 4222, Australia $1 https://orcid.org/0000000224782460 $7 xx0115772
- 700 1_
- $a Amati, Monica $u Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60126 Ancona, Italy
- 700 1_
- $a Santarelli, Lory $u Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60126 Ancona, Italy $1 https://orcid.org/0000000310157098
- 700 1_
- $a Tomasetti, Marco $u Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60126 Ancona, Italy $1 https://orcid.org/0000000150367052
- 700 1_
- $a Re, Massimo $u Department of Clinical and Molecular Sciences, Polytechnic University of Marche, 60126 Ancona, Italy
- 773 0_
- $w MED00173178 $t Cancers $x 2072-6694 $g Roč. 17, č. 24 (2025)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/41463190 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20260116 $b ABA008
- 991 __
- $a 20260122082549 $b ABA008
- 999 __
- $a ok $b bmc $g 2470224 $s 1267377
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2025 $b 17 $c 24 $e 20251209 $i 2072-6694 $m Cancers $n Cancers (Basel) $x MED00173178
- LZP __
- $a Pubmed-20260116